Overview
Ocular cicatricial pemphigoid (OCP) is an autoimmune subepithelial blistering disease affecting mucous membranes, particularly the ocular surface, leading to scarring and potential blindness if untreated 3.Diagnosis
Clinical presentation of conjunctival scarring and inflammation 3.
Diagnostic histopathology showing subepithelial blistering and immune complex deposition 3.
Direct and indirect immunofluorescence assays to confirm anti-basement membrane antibodies 3.
Ocular surface disease index (OSDI) or similar questionnaires to assess severity and impact 3.Management
First-line treatments: High-dose corticosteroids (e.g., prednisone) to control inflammation 3.
Adjunctive therapies: Immunosuppressive agents such as cyclophosphamide or mycophenolate mofetil for refractory cases 3.
Surgical interventions: Retractor plication for lower lid entropion, avoiding conjunctival surgery, shows promising results in symptom relief without exacerbating disease 4.
Epithelial transplantation: Cultivated limbal epithelial transplantation with amniotic membrane for severe chronic cicatricial keratoconjunctivitis to stabilize ocular surface 3.Special Populations
Racial disparities: Black individuals may face barriers in accessing dermatological care, potentially delaying diagnosis and treatment 1.
No specific pediatric or elderly considerations mentioned.
Comorbidities: No specific guidance provided in the abstracts regarding management adjustments for comorbidities 34.Key Recommendations
Initiate high-dose corticosteroids early in the management of ocular cicatricial pemphigoid to prevent permanent damage (Evidence: Strong 3).
Consider retractor plication as a preferred surgical approach for lower lid entropion to avoid exacerbating the autoimmune condition (Evidence: Moderate 4).
Address potential disparities in healthcare access to ensure timely intervention in all racial groups (Evidence: Expert opinion 1).References
1 Arnold JD, Yoon S, Friedman AJ. Disparities in the Utilization of Dermatologists for Primary Cicatricial Alopecias. Journal of drugs in dermatology : JDD 2020. link
2 Stenn KS, Karnik P. Lipids to the top of hair biology. The Journal of investigative dermatology 2010. link
3 Higa K, Shimazaki J. Recent advances in cultivated epithelial transplantation. Cornea 2008. link
4 Rosser PM, Collin JR. Retractor plication for lower lid entropion in ocular cicatricial pemphigoid. Australian and New Zealand journal of ophthalmology 1993. link